Sanofi · 1 day ago
Group Head Neurology Research
Cambridge, MA
Full-time
Onsite
Director/Executive
12+ years expSanofi is an R&D-driven, AI-powered biopharma company committed to improving people’s lives. They are seeking a Global Head of Neurology Research to lead cross-functional teams in the strategic and scientific direction for neurology drug discovery, aiming to deliver innovative pre-clinical drug candidate packages for clinical testing.
Health CareLife SciencePharmaceuticalTherapeutics
Responsibilities
Innovative and creative thinker and leader who applies disease area knowledge and uses cutting- edge technology to identify novel targets implicated in neurological disease
Lead a team of cross-functional scientists with the goal of delivering robust preclinical packages enabled by biomarkers across multiple modalities
Provide scientific insight and direction for multiple research programs using a diversity of modalities
Integrate large, diverse and complex data sets from multiple sources to inform on the most robust targets and pathways implicated in disease progression
Establish project priorities and resource allocations to ensure the highest impact
Leads by example across disciplines to execute on therapeutic area objectives
Ability to identify multidisciplinary solutions and recommend a course of action in ambiguous situations
Contributes to the vision, mission and tactics of the research therapeutic area and beyond
Support due diligence activities, competitive assessments, and evaluation of external opportunities
Serves as an inspirational leader within group, therapeutic area and beyond
Qualification
Required
PhD with at least 12 years of post-doctoral biopharma experience with demonstrated scientific leadership
Outstanding track record of scientific publications in high-impact journals with multiple publications as senior/corresponding author demonstrating thought leadership in neuroscience
Established national and international reputation as a Key Opinion Leader (KOL) in neuroscience, as evidenced by
Proven track record of significant scientific impact including: Multiple IND filings as a key scientific contributor or leader, Contributions to regulatory submissions (NDA/BLA), Successful progression of drug candidates from discovery through development, Patents with demonstrated commercial or therapeutic impact
Demonstrated ability to lead and influence across R&D through: Successful leadership of multidisciplinary teams achieving department/project objectives, Influential leadership outside of formal organizational structure, Track record of shaping scientific direction and influencing portfolio decisions
Strong business acumen with experience in due diligence, competitive intelligence, and strategic partnership evaluation
Extensive mentoring experience with track record of developing scientific talent and fostering scientific excellence
Highly self-directed and proactive with demonstrated ability to work independently in ambiguous situations and identify multidisciplinary solutions
Benefits
High-quality healthcare
Prevention and wellness programs
At least 14 weeks’ gender-neutral parental leave
Company
Sanofi
Sanofi is a global biopharma company focused on prescription drugs, vaccines, and treatments for chronic, rare, and infectious diseases.
10001+ employees
H1B Sponsorship
Sanofi has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (101)
2024 (68)
2023 (59)
2022 (78)
2021 (38)
2020 (38)
Funding
Current Stage
Public CompanyTotal Funding
$6.97BKey Investors
Blackstone Life SciencesEvotec
2025-10-28Post Ipo Debt· $3B
2025-06-17Post Ipo Debt· $1.74B
2025-03-05Post Ipo Debt· $1.59B
Leadership Team
Paul Hudson
Chief Executive Officer
Francois-Xavier Roger
Chief Financial Officer
Recent News
2026-01-06
BioWorld Financial Watch
2026-01-06
2026-01-06
Company data provided by crunchbase